Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease

Pediatric Blood and Cancer

Volumn 47, Issue 5, 2006, Pages 589-593

  Raffini, Leslie J ^a,c   Niebanck, Alison E ^b   Hrusovsky, Joanne ^a   Stevens, Amanda ^a   Blackwood Chirchir, Anne ^c   Ohene Frempong, Kwaku ^a,c   Kwiatkowski, Janet L ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Coagulation; Pediatrics; Prothrombin time; Sickle cell disease; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; VITAMIN K GROUP;

ADOLESCENT; ADULT; BLEEDING; BLOOD CLOTTING; FEMALE; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SCREENING TEST; SICKLE CELL ANEMIA; SURGICAL RISK; VITAMIN K DEFICIENCY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; DATABASES; DATABASES AS TOPIC; FEMALE; HUMANS; INFANT; MALE; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33748506104     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20579     Document Type: Review

References (13)

1. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The preoperative transfusion in sickle cell disease study group. N Engl J Med 1995;333:206-213.
2. Waldron P, Pegelow C, Neumayr L, et al. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: Perioperative morbidity. Preoperative transfusion in sickle cell disease study group. J Pediatr Hematol Oncol 1999;21:129-135.
3. Wright JG, Malia R, Cooper P, et al. Protein C and protein S in homozygous sickle cell disease: Does hepatic dysfunction contribute to low levels? Br J Haematol 1997;98:627-631.
4. Bayazit AK, Kilinc Y. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state. Pediatr Int 2001;43:592-596.
5. Rashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999;70:378-382.
6. Rucker RB. Improved functional endpoints for use in vitamin K assessment: Important implications for bone disease. Am J Clin Nutr 1997;65:883-884.
7. Gremse DA, Fillingim E, Hoff CJ, et al. Hepatic function as assessed by lidocaine metabolism in sickle cell disease. J Pediatr 1998;132:989-993.
8. Johnson CS, Omata M, Tong MJ, et al. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985;64:349-356.
9. Kurantsin-Mills J, Ofosu FA, Safa TK, et al. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 1992;81:539-544.
10. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998;91:4216-4223.
11. Buison AM, Kawchak DA, Schall J, et al. Low vitamin D status in children with sickle cell disease. J Pediatr 2004;145:622-627.
12. Broxson EH, Jr., Sokol RJ, Githens JH. Normal vitamin E status in sickle hemoglobinopathies in Colorado. Am J Clin Nutr 1989;50:497-503.
13. Sutie JW. The importance of menaquinones in human nutrition. Annual Review of Nutrition 1995;15:399-417.